Interventional Targeting of the IRE1alpha-TGFbeta signaling loop in pulmonary fibrosis
肺纤维化中 IRE1α-TGFβ 信号环路的介入靶向治疗
基本信息
- 批准号:10318632
- 负责人:
- 金额:$ 69.77万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-01-15 至 2023-12-31
- 项目状态:已结题
- 来源:
- 关键词:AerosolsApoptosisBleomycinCell DeathCell Differentiation processCellsCessation of lifeClinical ResearchCollagenComplexDevelopmentDiseaseDoseEndoplasmic ReticulumEndoribonucleasesEpithelialEpithelial CellsEtiologyEventExcisionExtracellular MatrixExtracellular Matrix ProteinsFeedbackFibroblastsFibrosisFunctional disorderFutureGeneticHeat-Shock Proteins 90HomeostasisHomoHumanHyperactivityInjuryIntegral Membrane ProteinIntegrinsInterventionLeadLearningLimb structureLinkLungMediatingMembraneMessenger RNAMicroRNAsModelingModificationMolecular ChaperonesMusOralOutcomeOutputPathogenesisPathologicPathway interactionsPatientsPharmaceutical PreparationsPharmacologyPhenocopyPhosphorylationPhosphotransferasesPlayProductionProfibrotic signalProtein SecretionProteinsPulmonary FibrosisPulmonary SurfactantsRNA SplicingReceptor Serine/Threonine KinaseRegulationReportingResolutionRibonucleasesRoleSecretory CellSignal PathwaySignal TransductionSystemTGF Beta Signaling PathwayTestingTransforming Growth Factor betaTransforming Growth Factor beta ReceptorsUp-RegulationWorkXBP1 geneacronymsalveolar epitheliumattenuationbasebiological adaptation to stresscell injurydimerendoplasmic reticulum stressepithelial injuryexperienceidiopathic pulmonary fibrosisin vivoinsightkinase inhibitormouse modelnanomolarnovelnovel drug classnovel therapeuticspreventresponsesenescenceskillssmall moleculetherapeutic targettooltranscription factortransdifferentiation
项目摘要
PROJECT SUMMARY/ABSTRACT
In this MPI RO1 application, we show that high endoplasmic reticulum (ER) stress and dysregulated unfolded
protein response (UPR) signaling in lungs precedes development of fibrosis in murine models of pulmonary
fibrosis (PF)—similar changes have been reported in lungs of human patients with idiopathic pulmonary
fibrosis (IPF). We find that the pathognomonic features of these changes are due to hyperactive signaling by
IRE1α, an ER transmembrane protein containing bifunctional kinase/endoribonuclease (RNase) catalytic
activities. We have found that novel, small molecule UPR kinase inhibitors of IRE1α, called KIRAs (an acronym
for kinase-inhibiting RNase attenuators) reduce IRE1α's destructive UPR signaling and show potent anti-
fibrotic effects in ER-stressed lungs of mice. Thus, even as IRE1α emerges as a potential therapeutic target for
treating human patients suffering from IPF, the underlying mechanistic basis for the cytoprotective, anti-fibrotic,
efficacy of the KIRA compounds needs to be understood. Through this application, we propose to understand
the basis of the KIRA-mediated salutary effects on reducing lung epithelial injury, dysregulation, and death,
and also on reducing collagen overproduction by activated fibroblasts. The project is enabled by the
complementary skill sets of two labs (Papa and Sheppard) that together have found the UPR is wired through
a signaling loop that leads to classical TGF-β-induced, pro-fibrotic signaling in lungs. Thus, the mechanistic
understanding to be gained from the successful completion of the proposed studies promises to reveal new
nodes and targets for rational disease modification in idiopathic pulmonary fibrosis, a currently incurable
disease.
项目摘要/摘要
在此MPI RO1应用中,我们显示高内质网(ER)应力和失调
肺部的蛋白质反应(UPR)信号先于肺模型的纤维化发展
纤维化(PF) - 在特发性肺部患者的肺中有类似的变化
纤维化(IPF)。我们发现这些变化的病理特征是由于过度活跃的信号引起的
IRE1α,一种含有双功能激酶/内核酸酶(RNase)催化的ER跨膜蛋白
活动。我们发现IRE1α的新型小分子UPR激酶抑制剂称为Kiras(首字母缩写词
对于抑制RNase衰减剂的激酶)减少IRE1α的破坏性UPR信号,并显示潜在的抗
小鼠ER压力肺的纤维化作用。即使IRE1α成为潜在的治疗靶标的
治疗患有IPF的人类患者,这是细胞保护,抗纤维化,
需要理解基拉化合物的功效。通过此应用,我们建议了解
基拉介导的对减少肺上皮损伤,失调和死亡的有益影响的基础
以及通过激活的成纤维细胞减少胶原蛋白过量产生的胶原蛋白。该项目由
两个实验室(爸爸和谢泼德)的完全技能共同发现了UPR通过
一个信号回路,导致经典的TGF-β诱导的肺部促纤维化信号传导。那,机械
从成功完成拟议研究的成功完成的理解有望揭示新的
特发性肺纤维化中合理疾病修饰的节点和靶标,目前无法治愈
疾病。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Small molecule inhibition of IRE1α kinase/RNase has anti-fibrotic effects in the lung.
IRE1α 激酶/RNase 的小分子抑制具有抗肺纤维化作用。
- DOI:10.1371/journal.pone.0209824
- 发表时间:2019
- 期刊:
- 影响因子:3.7
- 作者:Thamsen,Maike;Ghosh,Rajarshi;Auyeung,VincentC;Brumwell,Alexis;Chapman,HaroldA;Backes,BradleyJ;Perara,Gayani;Maly,DustinJ;Sheppard,Dean;Papa,FerozR
- 通讯作者:Papa,FerozR
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Feroz R Papa其他文献
Feroz R Papa的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Feroz R Papa', 18)}}的其他基金
Caraballo Diversity Supplement 093019
Caraballo 多样性补充剂 093019
- 批准号:
10026554 - 财政年份:2019
- 资助金额:
$ 69.77万 - 项目类别:
Drugs to combat ER stress-induced dysfunction of AECIIs/Sheppard
对抗 ER 应激引起的 AECIIs/Sheppard 功能障碍的药物
- 批准号:
8401271 - 财政年份:2012
- 资助金额:
$ 69.77万 - 项目类别:
Cytoprotection of Beta Cells Through Modulation of Ire1Alpha Function
通过调节 Ire1Alpha 功能对 Beta 细胞进行细胞保护
- 批准号:
7872760 - 财政年份:2009
- 资助金额:
$ 69.77万 - 项目类别:
Cytoprotection of Beta Cells Through Modulation of Ire1Alpha Function
通过调节 Ire1Alpha 功能对 Beta 细胞进行细胞保护
- 批准号:
8695105 - 财政年份:2009
- 资助金额:
$ 69.77万 - 项目类别:
Cytoprotection of Beta Cells Through Modulation of Ire1Alpha Function
通过调节 Ire1Alpha 功能对 Beta 细胞进行细胞保护
- 批准号:
8072535 - 财政年份:2009
- 资助金额:
$ 69.77万 - 项目类别:
Cytoprotection of Beta Cells Through Modulation of Ire1Alpha Function
通过调节 Ire1Alpha 功能对 Beta 细胞进行细胞保护
- 批准号:
8274825 - 财政年份:2009
- 资助金额:
$ 69.77万 - 项目类别:
Cytoprotection of Beta Cells Through Modulation of Ire1Alpha Function
通过调节 Ire1Alpha 功能对 Beta 细胞进行细胞保护
- 批准号:
8478087 - 财政年份:2009
- 资助金额:
$ 69.77万 - 项目类别:
Cytoprotection of Beta Cells Through Modulation of Ire1Alpha Function
通过调节 Ire1Alpha 功能对 Beta 细胞进行细胞保护
- 批准号:
9280930 - 财政年份:2009
- 资助金额:
$ 69.77万 - 项目类别:
Cytoprotection of Beta Cells Through Modulation of Ire1Alpha Function
通过调节 Ire1Alpha 功能对 Beta 细胞进行细胞保护
- 批准号:
7729655 - 财政年份:2009
- 资助金额:
$ 69.77万 - 项目类别:
Cytoprotection of Beta Cells Through Modulation of Ire1Alpha Function
通过调节 Ire1Alpha 功能对 Beta 细胞进行细胞保护
- 批准号:
9065686 - 财政年份:2009
- 资助金额:
$ 69.77万 - 项目类别:
相似国自然基金
基于巨噬细胞表型转变探讨BTSA1诱导衰老肌成纤维细胞凋亡及促肺纤维化消退的机制
- 批准号:82370077
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
STAB1调控Fas/FasL介导牦牛胎盘滋养层细胞凋亡及胎盘炎症性流产的作用与机制研究
- 批准号:32360836
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
ATAD3A琥珀酰化调控mtDNA损伤-泛凋亡反应轴在心梗后心衰中的作用研究
- 批准号:82300434
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
胸腺肽α-1介导凋亡小体RNA改善DC功能增强TNBC化疗后抗肿瘤免疫应答的机制研究
- 批准号:82303959
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
LSD1通过使组蛋白H3K4位点去甲基化促进自噬参与肾小管上皮细胞凋亡和肾脏纤维化的机制研究
- 批准号:82300769
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Impact of particle and ozone inhalation co-exposure on alveolar epithelial regeneration
颗粒物和臭氧吸入共同暴露对肺泡上皮再生的影响
- 批准号:
10579227 - 财政年份:2020
- 资助金额:
$ 69.77万 - 项目类别:
Impact of particle and ozone inhalation co-exposure on alveolar epithelial regeneration
颗粒物与臭氧吸入共同暴露对肺泡上皮再生的影响
- 批准号:
10356885 - 财政年份:2020
- 资助金额:
$ 69.77万 - 项目类别:
Impact of particle and ozone inhalation co-exposure on alveolar epithelial regeneration
颗粒物和臭氧吸入共同暴露对肺泡上皮再生的影响
- 批准号:
10153788 - 财政年份:2020
- 资助金额:
$ 69.77万 - 项目类别:
Caraballo Diversity Supplement 093019
Caraballo 多样性补充剂 093019
- 批准号:
10026554 - 财政年份:2019
- 资助金额:
$ 69.77万 - 项目类别: